Sökning: WFRF:(Paranjothy S)
> (2021) >
Determining post-op...
Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative-GO SOAR)
-
Gaba, F (författare)
-
Bizzarri, N (författare)
-
Kamfwa, P (författare)
-
visa fler...
-
Saiz, A (författare)
-
Blyuss, O (författare)
-
Paranjothy, S (författare)
-
Ramirez, PT (författare)
-
Cibula, D (författare)
-
visa färre...
- 2021-09-06
- 2021
- Engelska.
-
Ingår i: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. - : BMJ. - 1525-1438. ; 31:9, s. 1287-1291
- Relaterad länk:
-
https://aura.abdn.ac...
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) aims to develop a network of gynecological oncology surgeons, surgical departments, and other interested parties that will have the long-term ability to collaborate on outcome studies. The protocol for the first collaborative study is presented here.Primary ObjectiveTo evaluate international variation in 30-day post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings.HypothesisThere is no variation in post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings.Study DesignInternational, multicenter, prospective cohort study. Patient data will be collected over a consecutive 30-day period through gynecological oncology multidisciplinary teams/tumor boards and clinics across different human development index country groups. All data are collected on a customized, secure, password protected, central REDCap database.Major Inclusion/Exclusion CriteriaInclusion criteria include women aged ≥18 years undergoing elective/emergency, curative/palliative surgery for primary/recurrent tubo-ovarian/peritoneal, endometrial, cervical, vulval, vaginal, gestational trophoblastic malignancies. Surgical modality may be open, minimal access (laparoscopic/robotic), or vaginal.Primary Endpoint30-day post-operative morbidity and mortality defined as per Clavien-Dindo classification system.Sample Size1100 (550/arm).Estimated Dates for Completing Accrual and Presenting ResultsIt is estimated recruitment will be completed by 2022 and results published by 2023.Trial RegistrationClinicalTrials.gov registry: NCT04579861 (https://clinicaltrials.gov/ct2/show/NCT04579861).
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas